KathrynA.BylowMD

Oncology • Milwaukee, WI

Genitourinary Oncology

Associate Professor, Medicine, Medical College of Wisconsin

Join to view full profile

Dr. Bylow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bylow's full profile

Already have an account?

Office
9200 W Wisconsin Ave
Clinical Cancer Center
Milwaukee, WI 53226
Phone+1 414-805-4600

Fax+1 414-805-4606
Is this information wrong?

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 2004 - 2007
Vanderbilt University Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Wisconsin School of Medicine & Public HealthClass of 2000

Certifications & Licensure

WI State Medical License 2007 - 2025
IL State Medical License 2003 - 2008

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Start of enrollment: 2010 Jan 01
Completed
Phase 1, Phase 2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation Start of enrollment: 2014 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very...
William A. Hall, Meena Bedi, Deepak Kilari, Kathryn A. Bylow, John D. Burfeind, Candice Johnstone, Malika Siker, Adam Currey, William A. See, Ariel Ann Nelson, Scott J...> ;Practical Radiation Oncology. 2021 Apr 10
1 citations
Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience.
Michael Pierro, Ruben Raychaudhuri, William B. Lea, William S. Rilling, Nancy B. Davis, Kathryn A. Bylow, Deepak Kilari> ;Clinical Genitourinary Cancer. 2021 Feb 1
4 citations
The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?
Emily Lemke, Deepak M. Sahasrabudhe, Elizabeth A. Guancial, Kathryn A. Bylow, Scott Johnson, Edward M. Messing, Deepak Kilari> ;Clinical Genitourinary Cancer. 2020 Jan 27
14 citations
Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm.
Ruben Raychaudhuri, Matthew J. Riese, Kathryn A. Bylow, John D. Burfeind, Alexander C. Mackinnon, Parag Tolat, Deepak Kilari> ;Clinical Genitourinary Cancer. 2017 May 25
11 citations
Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).
Ehab Atallah, Kathryn A. Bylow, Jesse D. Troy, Wael Saber> ;Current Hematologic Malignancy Reports. 2014 Jan 8
80 citations
Double-Blind, Randomized, Phase 2 Trial of Maintenance Sunitinib Versus Placebo After Response to Chemotherapy in Patients With Advanced Urothelial Carcinoma
Petros Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn A. B...> ;Cancer. 2014 Mar 1
10 citations
The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study
Erika Ramsdale, Blase N. Polite, Joshua Hemmerich, Kathryn A. Bylow, Hedy L. Kindler, Supriya G. Mohile, William Dale> ;Journal of the American Geriatrics Society. 2013 Nov 1
44 citations
Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study.
Kathryn A. Bylow, Joshua Hemmerich, Supriya G. Mohile, Walter M. Stadler, Saleha Sajid, William Dale> ;Urology. 2011 Apr 1
53 citations
Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer
Supriya G. Mohile, Maureen Lacy, Miriam B. Rodin, Kathryn A. Bylow, William Dale, Michael R. Meager, Walter M. Stadler> ;Critical Reviews in Oncology/hematology. 2010 Aug 1
43 citations
Management of complications of androgen deprivation therapy in the older man
Supriya G. Mohile, Karen M. Mustian, Kathryn A. Bylow, William J. Hall, William Dale> ;Critical Reviews in Oncology/hematology. 2009 Jun 1
WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer
Supriya G. Mohile, Maureen Lacy, Miriam B. Rodin, Kathryn A. Bylow, William Dale, Michael R. Meager, Walter M. Stadler> ;Critical Reviews in Oncology/hematology. 2009 May 14
40 citations
Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospec...
William Dale, Joshua Hemmerich, Kathryn A. Bylow, Supriya G. Mohile, Mary Mullaney, Walter M. Stadler> ;Journal of Clinical Oncology. 2009 Apr 1
16 citations
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
Kathryn A. Bylow, Michael B. Atkins, Edwin M. Posadas, Walter M. Stadler, David F. McDermott> ;Clinical Genitourinary Cancer. 2009 Jan 1
104 citations
Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.
Kathryn A. Bylow, William Dale, Karen M. Mustian, Walter M. Stadler, Miriam B. Rodin, William J. Hall, Mark S. Lachs, Supriya G. Mohile> ;Urology. 2008 Aug 1
86 citations
Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.
Kathryn A. Bylow, Supriya G. Mohile, Walter M. Stadler, William Dale> ;Cancer. 2007 Dec 15
44 citations
Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid
Christopher W. Ryan, Dezheng Huo, Kathryn A. Bylow, Laurence M. Demers, Walter M. Stadler, Tara O. Henderson, Nicholas J. Vogelzang> ;BJU International. 2007 Jul 1
27 citations
Pancreatic cancer : An update
Hedy L. Kindler, Kathryn A. Bylow> ;Current Oncology Reports. 2007 Apr 26
181 citations
A pilot study of the vulnerable elders survey‐13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer...
Supriya G. Mohile, Kathryn A. Bylow, William Dale, James J. Dignam, Kandis Martin, Daniel P. Petrylak, Walter M. Stadler, Miriam B. Rodin> ;Cancer. 2007 Feb 15
1 citations
Temporal arteritis: The importance of recognizing senescent changes versus quiescent disease in a temporal artery biopsy.
Kathryn A. Bylow, Daniel J. Brauner> ;Journal of the American Geriatrics Society. 2006 Dec 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Froedtert and the Medical College of Wisconsin Froedtert HospitalMilwaukee, Wisconsin